loading

Cyclerion Therapeutics Inc Azioni (CYCN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
840.86%
0.875
0.093 0.081 1.806 0.194
Operating Expenses
6.57%
1.881
1.765 1.538 1.304 1.322
Benefits Costs and Expenses
-
- 1.51 1.276 0.917
Costs And Expenses
6.57%
1.881
1.765 1.51 1.276 0.917
Operating Income/Loss
39.83%
-1.006
-1.672 -1.457 0.502 -1.128
Nonoperating Income/Loss
97.77%
0.03
1.348 0.028 0.028 0.405
Income/Loss From Continuing Operations Before Tax
370.06%
0.875
-0.324 -1.429 0.53 -0.723
Income/Loss From Continuing Operations After Tax
201.23%
-0.976
-0.324 -1.429 0.53 -0.723
Net Income/Loss
201.23%
-0.976
-0.324 -1.429 0.53 -0.723
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5.01%
3.225
3.071 2.556 0.008 2.526
Diluted Average Shares
5.01%
3.225
3.071 2.556 0.008 2.526
Basic Earnings Per Share
172.73%
-0.30
-0.11 -0.56 0.22 -0.29
Diluted Earnings Per Share
172.73%
-0.30
-0.11 -0.56 0.22 -0.29
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):